Oncostatin M receptor deficiency as a novel candidate genetic cause of autosomal recessive hyper-IgE syndrome
Hyper-IgE syndrome (HIES) is characterized by elevated serum IgE levels, eczema, and recurrent skin and pulmonary infections, classically caused by autosomal dominant (AD) STAT3 loss-of-function variants. Here we describe a patient presenting with elevated IgE levels, atopic eczema, chronic pulmonary aspergillosis, and bone fractures, homozygous for a rare missense variant in the oncostatin M receptor (<i>OSMR</i>) gene. We demonstrate that the patient OSMR V436D variant is deleterious and leads to decreased OSMR surface expression and impaired OSM-induced STAT3 phosphorylation. Blood profiling showed elevated IgE-expressing plasmablasts and peripheral T follicular helper cells and atypical memory B cells. A germinal center model revealed a B cell-extrinsic defect in concordance with a largely fibroblast-confined phenotype. Finally, reconstitution of patient fibroblasts led to functional complementation of the cellular phenotype. We propose OSMR deficiency as a novel genetic etiology of AR-HIES, resembling the clinical and immunological phenotype of STAT3 AD-HIES, but mediating its phenotypic profile mainly in the stromal rather than hematopoietic compartment.
Authors
- Christoffer Dellgren (ORCID: https://orcid.org/0000-0003-4841-5187)
- J.B. Jensen
- Daniëla Maria Hinke (ORCID: https://orcid.org/0000-0002-3932-8762)
- Kristian Assing (ORCID: https://orcid.org/0000-0001-8744-1615)
- Line Dahlerup Rasmussen (ORCID: https://orcid.org/0000-0003-0853-0893)
- S.H. Andersen (ORCID: https://orcid.org/0009-0006-6090-1996)
- Søren E Degn
- Trine H. Mogensen
- Christian B. Laursen
Institutions
- Aarhus University (DK)
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- Journal of Human Immunity
- Published
- 2026-02-03
- DOI
- https://doi.org/10.70962/jhi.20250119
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Aarhus Universitet
- Innovationsfonden
- National Research Foundation
- Danmarks Grundforskningsfond
- Aase og Ejnar Danielsens Fond
- Lundbeckfonden
- Novo Nordisk
- Frimodt-Heineke Fonden
- Kong Christian den Tiendes Fond
- Novo Nordisk Fonden
- H. Lundbeck A/S